Company intelligence / Profile preview

Apheresis Research Institute Cologne

Cologne, North Rhine-Westphalia, Germanyapheresis-research.org ↗

Ownership: Private
Development stage: Other

Overview

The Apheresis Research Institute (AFI) is a clinical research and academic organization focused on extracorporeal blood purification and therapeutic apheresis. It conducts clinical studies, develops and publishes consensus guidelines, and performs quality assurance methodologies for these therapies, particularly for rare lipid disorders. AFI collaborates extensively with academic and healthcare institutions globally.

Therapeutic areas: Metabolic DisordersCardiovascular
Modalities: DeviceBlood Component RemovalTherapeutic apheresis
Industry: Academic Hospital/University/Research

Partnerships

Universities and medical centers in Germany, Europe, USA, and Japan

Beyond the preview

Go deeper on Apheresis Research Institute Cologne.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apheresis Research Institute Cologne.

Explore the full profile